OK
The Universal Selection Source:
Adhesives Ingredients
Industry News

Verdezyne Signs Distribution Agreement with CBC for Biobased Dodecanedioic Acid

Published on 2016-03-09. Author : SpecialChem

Verdezyne
Fig. 1: Verdezyne

CARLSBAD & SAN FRANCISCO, Calif. -- Verdezyne, Inc., a synthetic biology company producing biobased chemicals, and Connell Bros. Co. LLC (CBC), one of the largest marketers and distributors of specialty chemicals in the Asia-Pacific region, announced an agreement for sales and distribution of Verdezyne’s BIOLON™ DDDA (biobased dodecanedioic acid or “DC12”). BIOLON™ DDDA will be produced at Verdezyne’s commercial-scale plant in Malaysia and will be distributed in 17 countries throughout Asia-Pacific, including China, Japan and South Korea. The agreement assures CBC of access to more than 10% of the expected plant capacity.


Verdezyne’s BIOLON™ DDDA is produced more sustainably than traditional petroleum-derived intermediate chemicals and will be used to make a variety of end-user products including automotive parts, toothbrush bristles, cosmetics, and fragrances.
Connell Bros. Co. LLC
Fig. 2: Connell Bros. Co. LLC

“This agreement with CBC reflects the strong interest in high quality renewable chemicals such as our BIOLON™ DDDA,” said E. William Radany, Ph.D., president and CEO of Verdezyne. “As one of the largest and most respected distributors of specialty chemicals in the Asia-Pacific region, CBC is a strong partner for us. We are sure this agreement marks the beginning of a long and mutually-beneficial relationship.”

Verdezyne’s plant, expected to be completed in 2017, is anticipated to have the capacity to produce up to 9,000 metric tons of diacids including BIOLON™ DDDA annually.

“Verdezyne presented us with a very strong value proposition,” commented Scott Graddy, vice president, CBC. “We anticipate a strong demand for BIOLON™ DDDA from our customers in Asia-Pacific. We are very pleased to have reached this agreement with Verdezyne and we look forward to distributing BIOLON™ DDDA throughout the region.”

About Verdezyne

Verdezyne is an industrial biotechnology company using proven and proprietary metabolic pathway engineering tools to develop unique yeast strains for cost-effective production of biobased chemicals. Current investors in Verdezyne include BP Alternative Energy Ventures, DSM Venturing B.V., OVP Venture Partners, Monitor Ventures, and Sime Darby.

About Connell Bros. Co.

Founded in 1895, Connell Bros. Co. LLC is one of the Wilbur-Ellis family of companies and is the largest marketer and distributor of specialty chemicals and ingredients in Asia-Pacific with a keen focus on technical service, customer support, and environmental, health, and safety. Connell Brothers provides complete supply chain management from transportation, documentation, warehousing, and sales and distribution in 17 countries and in 47 offices located throughout Asia-Pacific.

Source: Verdezyne

PS: If you liked this News, you might enjoy our Adhesives Industry Newsletter. All the Industry News delivered once a week right to your inbox. Sign up here!


FEICA 2018 European Adhesive and Sealant Conference and EXPO
Back to Top